# Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects

> **NCT01597895** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Maraviroc
- **DRUG:** Maraviroc + Boceprevir
- **DRUG:** Maraviroc + Telaprevir

## Key facts

- **NCT ID:** NCT01597895
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2012-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01597895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01597895, "Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01597895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*